Avalo Therapeutics Inc. buy Jefferies Financial Group Inc.
Start price
25.03.25
/
50%
€0.041
Target price
25.03.26
€21.28
Performance (%)
-
End price
26.03.26
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Avalo Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 4,24 % | 2,86 % | 14,03 % |
| iShares Nasdaq 100 | 4,89 % | 2,81 % | 32,71 % |
| iShares Nikkei 225® | 9,40 % | 7,83 % | 48,30 % |
| iShares S&P 500 | 3,53 % | 1,95 % | 25,25 % |
Comments by Jefferies_Financial_ for this prediction
In the thread Avalo Therapeutics Inc. diskutieren
Avalo Therapeutics, Inc. (NASDAQ: AVTX) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $23.00 price target on the stock.
Ratings data for AVTX provided by MarketBeat
In the thread Trading Avalo Therapeutics Inc.
Die von Jefferies_Financial_ gewählte maximale Laufzeit wurde überschritten